A thermostable, chromatographically purified Ebola nano-VLP vaccine

por Carra, John H, Martins, Karen A O, Schokman, Rowena D, Robinson, Camenzind G, Steffens, Jesse T, Bavari, Sina
Publicado 2015

T-cell-dependent mechanisms promote Ebola VLP-induced antibody responses, but are dispensable for vaccine-mediated protection

por Cooper, Christopher L, Martins, Karen A, Stronsky, Sabrina M, Langan, David P, Steffens, Jesse, Van Tongeren, Sean, Bavari, Sina
Publicado 2017

411. Does an Early Cytokine Response During Ebola Virus Disease Improve the Duration of Survival in Rhesus Macaques?

por Blair, Paul W, Martins, Karen A O, Maryam, Keshtkar-Jahromi, Kortepeter, Mark G, Michael, Keebaugh, Downs, Isaac L, Cardile, Anthony P
Publicado 2019

Toll-Like Receptor Agonist Augments Virus-Like Particle-Mediated Protection from Ebola Virus with Transient Immune Activation

por Martins, Karen A. O., Steffens, Jesse T., van Tongeren, Sean A., Wells, Jay B., Bergeron, Alison A., Dickson, Samuel P., Dye, John M., Salazar, Andres M., Bavari, Sina
Publicado 2014

Development of a liquid chromatography high resolution mass spectrometry method for the quantitation of viral envelope glycoprotein in Ebola virus-like particle vaccine preparation...

por Cazares, Lisa H., Ward, Michael D., Brueggemann, Ernst E., Kenny, Tara, Demond, Paul, Mahone, Christopher R., Martins, Karen A. O., Nuss, Jonathan E., Glaros, Trevor, Bavari, Sina
Publicado 2016

Adjuvant-enhanced CD4 T Cell Responses are Critical to Durable Vaccine Immunity

por Martins, Karen A.O., Cooper, Christopher L., Stronsky, Sabrina M., Norris, Sarah L.W., Kwilas, Steven A., Steffens, Jesse T., Benko, Jacqueline G., van Tongeren, Sean A., Bavari, Sina
Publicado 2015

The Evolution of Medical Countermeasures for Ebola Virus Disease: Lessons Learned and Next Steps

por Crozier, Ian, Britson, Kyla A., Wolfe, Daniel N., Klena, John D., Hensley, Lisa E., Lee, John S., Wolfraim, Larry A., Taylor, Kimberly L., Higgs, Elizabeth S., Montgomery, Joel M., Martins, Karen A.
Publicado 2022

The Joint Mobile Emerging Disease Clinical Capability (JMEDICC) laboratory approach: Capabilities for high-consequence pathogen clinical research

por Naluyima, Prossy, Kayondo, Willy, Ritchie, Chi, Wandege, Joseph, Kagabane, Sharon, Tumubeere, Lydia, Kusiima, Brenda, Kibombo, Daniel, Atukunda, Sharon, Nanteza, Christine, Nabirye, Harriet, Mugabi, Francis Bunjo, Namuyanja, Sarah, Hatcher, Christopher, Rauch, Hypaitia, Mukembo, Moses, Musinguzi, Patrick, Sanders, Nathan, Turesson, Elizabeth, Cando, Christian, Walwema, Richard, Mimbe, Derrick, Hepburn, Janice, Clark, Danielle, Lamorde, Mohammed, Kibuuka, Hannah, Zaman, Saima, Cardile, Anthony P., Martins, Karen A.
Publicado 2019

Recent successes in therapeutics for Ebola virus disease: no time for complacency

por Iversen, Patrick L, Kane, Christopher D, Zeng, Xiankun, Panchal, Rekha G, Warren, Travis K, Radoshitzky, Sheli R, Kuhn, Jens H, Mudhasani, Rajini R, Cooper, Christopher L, Shurtleff, Amy C, Nasar, Farooq, Sunay, Melek ME, Duplantier, Allen J, Eaton, Brett P, Zumbrun, Elizabeth E, Bixler, Sandra L, Martin, Shannon, Meinig, J Matthew, Chiang, Chih-Yuan, Sanchez-Lockhart, Mariano, Palacios, Gustavo F, Kugelman, Jeffrey R, Martins, Karen A, Pitt, Margaret L, Crozier, Ian, Saunders, David L
Publicado 2020